Evidence map›Paper›PMID 40325876›Full record

ArticleBrain pathology (Zurich, Switzerland)2025

Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patients.

Jessica A Beck, Christina Mazcko, Sara Belluco, Mireille Bitar, Daniel Brat, Jonathan W Bush, Rati Chkheidze, Kara N Corps, Chad Frank, Caterina Giannini and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jessica A BeckComparative Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-0145-7606
Christina MazckoComparative Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Sara BellucoUniversité de Lyon, VetAgro Sup, UPSP 2021.A104 ICE 'Interactions Cellules Environnement', Axe Cancérologie, Lyon, France.
Mireille BitarDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Daniel BratDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Jonathan W BushDepartment of Pathology and Laboratory Medicine, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Rati ChkheidzeDepartment of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kara N CorpsDepartment of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
Chad FrankDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
Caterina GianniniLaboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, New York, USA.
Craig HorbinskiDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID 0000-0001-8340-9992
Jason T HuseDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0003-4514-0640
Jennifer W KoehlerDepartment of Pathobiology, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA.
Andrew D MillerDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
C Ryan MillerDepartment of Pathology, UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
M Gerard O'SullivanDepartment of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, USA.
Joanna J PhillipsDepartment of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-3789-8120
Daniel R RissiAthens Veterinary Diagnostic Laboratory, Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
Courtney R SchottDepartment of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Anat Stemmer-RachamimovDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Stephen YipDepartment of Pathology and Laboratory Medicine, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Amy K LeBlancComparative Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Funding

NCI NIH HHS Z01-BC006161
6 · The paper itself

Abstract

Comparative pathology boards bring together anatomic pathologists with expertise in canine and human histology to identify shared features, including immune or TME components, tumor subtypes, or prognostic tissue biomarkers. This article summarizes feedback to improve future initiatives and enhance the translational relevance of comparative oncology for human patients.

Indexed as

NeoplasmsAnimalsDogsHumansPathologistsTranslational Research, Biomedicalanimal disease modelscomparative oncologygliomahistologymeningiomapathology

Identifiers

PMID40325876
PMCPMC12352920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.